No evidence found of offensive bioweapons program in India

A recent report on India's biological weapons capacity found that there is no evidence in the country's public domain that it ever pursued an offensive bioweapons program.

In 2003, the U.S. Congressional Research Service asserted that there was a potential danger of India developing a bioweapons program. The service said that India contained an active biological defense research program and the necessary infrastructure to develop various biological agents.

The BioWeapons Monitor 2012 report released in December reported on India's status in relation to biological weapons, reports.

The report was released as part of the BioWeapons Prevention Project, a network of actors with the goal of permanently eliminating biological weapons. In the report, there was no evidence provided related to the country pursing an offensive bioweapons program.

The country was, however, found to have a flourishing biotechnology industry and an improving program for biodefense.

According to a 2010 estimate, there are approximately 380 biotechnology companies in India with speculation about a $25 billion research and development spending increase in the sector in the next 15 years. The biotechnology and healthcare sectors in India are projected to have $100 billion in revenue by 2025.

The report found that India's National Disaster Management Authority has 400 security personnel trained to handle man-made biological, chemical, radiological and nuclear emergencies in and around the Parliament House. The country is also building a multipurpose NBC institute in Nagpur for the research, development and training for the military by 2016, reports.